J.-P. Stasch

877 total citations
31 papers, 696 citations indexed

About

J.-P. Stasch is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, J.-P. Stasch has authored 31 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Cardiology and Cardiovascular Medicine and 8 papers in Physiology. Recurrent topics in J.-P. Stasch's work include Nitric Oxide and Endothelin Effects (7 papers), Heart Failure Treatment and Management (6 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). J.-P. Stasch is often cited by papers focused on Nitric Oxide and Endothelin Effects (7 papers), Heart Failure Treatment and Management (6 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). J.-P. Stasch collaborates with scholars based in Germany, Czechia and Japan. J.-P. Stasch's co-authors include D. Neuser, S. Kazda, Claudia Hirth‐Dietrich, Joachim Mittendorf, Werner Seeger, Ralph T. Schermuly, Friedrich Grimminger, Hossein Ardeschir Ghofrani, Norbert Weißmann and S. Kazda and has published in prestigious journals such as FEBS Letters, Hypertension and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

J.-P. Stasch

30 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.-P. Stasch Germany 13 340 256 227 192 84 31 696
H. Meyer-Lehnert Germany 17 216 0.6× 246 1.0× 93 0.4× 259 1.3× 61 0.7× 45 659
Eva Maria Becker Germany 7 327 1.0× 348 1.4× 100 0.4× 335 1.7× 49 0.6× 11 720
Yoshikatsu Tabuchi Japan 9 373 1.1× 389 1.5× 85 0.4× 165 0.9× 124 1.5× 19 689
Andrew L. McCarthy United Kingdom 10 278 0.8× 339 1.3× 75 0.3× 72 0.4× 47 0.6× 12 935
János Pataricza Hungary 13 370 1.1× 109 0.4× 57 0.3× 155 0.8× 59 0.7× 34 598
Toshiko Kanbe Japan 10 193 0.6× 151 0.6× 49 0.2× 162 0.8× 111 1.3× 12 483
Michiaki Okumura Japan 19 336 1.0× 254 1.0× 81 0.4× 303 1.6× 222 2.6× 41 969
Pascale Plas France 14 198 0.6× 163 0.6× 101 0.4× 207 1.1× 52 0.6× 24 623
Richard P.E. van Dokkum Netherlands 18 393 1.2× 163 0.6× 92 0.4× 140 0.7× 133 1.6× 26 805
Lars Bøgeskov Nielsen Denmark 11 102 0.3× 163 0.6× 93 0.4× 144 0.8× 46 0.5× 15 557

Countries citing papers authored by J.-P. Stasch

Since Specialization
Citations

This map shows the geographic impact of J.-P. Stasch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-P. Stasch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-P. Stasch more than expected).

Fields of papers citing papers by J.-P. Stasch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-P. Stasch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-P. Stasch. The network helps show where J.-P. Stasch may publish in the future.

Co-authorship network of co-authors of J.-P. Stasch

This figure shows the co-authorship network connecting the top 25 collaborators of J.-P. Stasch. A scholar is included among the top collaborators of J.-P. Stasch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-P. Stasch. J.-P. Stasch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lanaro, Carolina, Camila Bononi Almeida, Lidiane S. Torres, et al.. (2020). Beneficial Effects of Soluble Guanylyl Cyclase Stimulation and Activation in Sickle Cell Disease Are Amplified by Hydroxyurea: In Vitro and In Vivo Studies. Journal of Pharmacology and Experimental Therapeutics. 374(3). 469–478. 12 indexed citations
2.
Jabs, Alexander, Matthias Oelze, Yuliya Mikhed, et al.. (2015). Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats. Vascular Pharmacology. 71. 181–191. 28 indexed citations
3.
Dahal, Bhola K., Djuro Kosanovic, Akylbek Sydykov, et al.. (2010). Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension. European Respiratory Journal. 36(4). 808–818. 44 indexed citations
4.
Schermuly, Ralph T., J.-P. Stasch, Soni Savai Pullamsetti, et al.. (2008). Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension. European Respiratory Journal. 32(4). 881–891. 188 indexed citations
5.
Kast, R., Hartmut Schirok, Santiago Figueroa‐Pérez, et al.. (2007). Cardiovascular effects of a novel potent and highly selective azaindole‐based inhibitor of Rho‐kinase. British Journal of Pharmacology. 152(7). 1070–1080. 56 indexed citations
6.
Buz, Semih, et al.. (2005). Humoral and hemodynamic responses after left ventricular assist device implantation and heart transplantation. The Thoracic and Cardiovascular Surgeon. 53(S 01). 3 indexed citations
7.
Bischoff, Erwin, Matthias Schramm, Alexander Straub, Achim Feurer, & J.-P. Stasch. (2003). BAY 41-2272: a stimulator of soluble guanylyl cyclase induces nitric oxide-dependent penile erection in vivo. Urology. 61(2). 464–467. 55 indexed citations
8.
Wegner, Max, et al.. (1995). Interaction of a Neutral Endopeptidase Inhibitor with an ANP-C Receptor Ligand in Anesthetized Dogs. Clinical and Experimental Hypertension. 17(6). 861–876. 9 indexed citations
9.
Drexler, H., Claudia Hirth‐Dietrich, J.-P. Stasch, et al.. (1991). Endogenous atrial natriuretic factor is involved in the natriuresis following sodium loading in rats with chronic heart failure. Cardiovascular Research. 25(7). 558–564. 2 indexed citations
10.
Heidemann, Franziska, Wolfram Steinke, U. Pleiß, et al.. (1991). Autoradiographic localizatio of [125I]-C-ANP compared to [125I]-ANP in rat tissue. Histochemistry and Cell Biology. 96(4). 317–321. 3 indexed citations
11.
Neuser, D., Claudia Hirth‐Dietrich, J.-P. Stasch, & S. Kazda. (1990). Influence of Calcium Antagonists on Renal Function and Secondary Hyperparathyroidism in Acute Renal Failure in Rats. Renal Failure. 12(4). 221–225. 2 indexed citations
12.
Lenz, Petra H., et al.. (1990). Therapy of diseased stroke-prone spontaneously hypertensive rats with nimodipine.. PubMed. 21(12 Suppl). IV111–2. 4 indexed citations
13.
Stasch, J.-P., et al.. (1989). Endothelin stimulates release of atrial natriuretic peptides in vitro and in vivo. Life Sciences. 45(10). 869–875. 68 indexed citations
14.
Stasch, J.-P. & S. Kazda. (1989). Endothelin-1-Induced Vascular Contractions. Journal of Cardiovascular Pharmacology. 13. S63–66. 23 indexed citations
16.
Stasch, J.-P., et al.. (1987). The Renal Response to Acute Hypervolemia Is Caused by Atrial Natriuretic Peptides. Survey of Anesthesiology. 31(1). 6–6. 7 indexed citations
17.
Stasch, J.-P., et al.. (1987). Role of nisoldipine on blood pressure, cardiac hypertrophy, and atrial natriuretic peptides in spontaneously hypertensive rats.. Hypertension. 10(3). 303–307. 17 indexed citations
18.
Stasch, J.-P., et al.. (1987). The use of a monoclonal antibody for the determination of atrial natriuretic peptides in human plasma. Journal of Molecular Medicine. 65(12). 533–537. 4 indexed citations
19.
Garthoff, B, et al.. (1987). Renal Effects of 1,4-Dihydropyridines in Animal Models of Hypertension and Renal Failure. Journal of Cardiovascular Pharmacology. 9. S8–S13. 7 indexed citations
20.
Neuser, D., Klaus‐Peter Lesch, J.-P. Stasch, & H. Przuntek. (1984). Beta-Endorphin-, Leucine Enkephalin- and Methionine Enkephalin-Like Immunoreactivity in Human Cerebrospinal Fluid. European Neurology. 23(2). 73–81. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026